Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 26, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Fluoride – our newest approach to fighting antibiotic resistance bacteria

UV-linked mutations can shape genome sequence changes!

Main protease enzyme of SARS CoV-2 against COVID-19

Fluoride – our newest approach to fighting antibiotic resistance bacteria
  • BiotechToday
  • World

Fluoride – our newest approach to fighting antibiotic resistance bacteria

bioxone January 20, 2021January 20, 2021

Sumedha Guha, Techno India University

One of the growing challenges of the modern world is the rise in the number of antibiotic-resistant bacteria. Two main causes of this problem can be traced back to the overuse of antibiotics as prescription drugs and rise in the usage of antibiotics as selection markers in laboratory experiments. Michelle O’Malley’s Lab in UC Santa Barbara addresses both these issues and presents to us a solution of replacing antibiotics used in the lab with fluoride. 

In most genetic engineering experiments in the lab, altered GMOs (genetically modified organisms) with antibiotic resistance genes are used as selective markers. For this, a plasmid (circular, extra-chromosomal DNA, usually present in prokaryotes which confer certain specific characteristics to the organism like, antibiotic resistance) with an antibiotic resistance marker is utilized so that the bacterial strain can survive in a culture where the same antibiotic is introduced. Justin Yoo, a graduate researcher at O’Malley’s Lab has proposed to replace the antibiotics used here with fluoride.

Scientists have known for decades the aberrant nature of fluoride as a chemical as well it’s abundance in the natural world. Fluoride is abundant in natural water sources and is toxic to microorganisms. It is for this reason that most microorganisms have evolved around this and have a gene that encodes a fluoride exporter. The job of this exporter molecule is to protect the living cells by removing fluoride ions that get introduced into their body from the surrounding environment.

In studies that took about a month to complete, Justin observed that bacteria which were genetically modified by a method called homologous recombination to render the gene that encodes fluoride exporter in the cell non-functional died. This method also stands to address the economic limitation faced by antibiotic cell selection in biotechnology labs. Not only does using antibiotics cause a chain reaction and end up increasing the resistant strains of bacteria but also, in the long run, the economic load amounts to a huge sum. Both of these problems could be solved using a chemical like a fluoride. This relatively safe, abundant and cheap chemical would be helping labs across the globe cut down significantly on fermentation costs as well as ensuring a halt in the rising number of altered strains of antibiotic-resistant bacteria.

Also read:UV-linked mutations can shape genome sequence changes!

SOURCE:  https://www.nature.com/articles/s41467-020-19271-1

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antibiotic-resistant bacteria antibiotics bacteria Biotechnology genetic engineering Genetics GMO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Main protease enzyme of SARS CoV-2 against COVID-19

bioxone January 21, 2021

-Rohit Bhattacharjee, Amity University Kolkata Coronavirus 2019 – the episode is a worldwide pandemic brought about by (SARS-CoV-2) which at first analyzed in Chinese patients of Hubei’s Wuhan city toward the beginning of December 2019. COVID-19 has been proclaimed a worldwide wellbeing catastrophe by World Health Organization (WHO) as the illness quickly communicated human-to-human and […]

Related Post

  • BiotechToday
  • World

ODM-207 – First-in-human Phase 1 study of BET inhibitor for solid tumour patients

bioxone October 1, 2020October 1, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours.  The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

LDLR and its role in Hepatitis B infection

bioxone July 25, 2021July 24, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics HBV – Hepatitis B virus infects more than 200 million people around the world. The virus results in liver diseases such as hepatitis, cirrhosis, fibrosis, and hepatocellular carcinoma (HCC). Prophylactic HBV vaccine reduces the number of infections but fails to offer a therapeutic benefit to chronically […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

DNA tales September 22, 2023October 1, 2023

Dr. Mona Amit Kaushal, Arihant School of Pharmacy & Bio-Research Institute, Gujarat Technological University Why a methanol vapour sensor at all? Researchers are currently exploring customized molecular recognition of analytes and employing cutting-edge methods to observe changes in recognition elements. They aim to develop exceptionally sensitive and precise biosensors. Biology offers numerous examples of precise […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy